BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23633311)

  • 21. Surfactant lavage decreases systemic interleukin-1 beta production in meconium aspiration syndrome.
    Wang PW; Jeng MJ; Wang LS; Fang LJ; Soong WJ
    Pediatr Int; 2010 Jun; 52(3):432-7. PubMed ID: 19919635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracheal suction at birth in non-vigorous neonates born through meconium-stained amniotic fluid.
    Nangia S; Thukral A; Chawla D
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD012671. PubMed ID: 34133025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
    Lemyre B; Davis PG; De Paoli AG; Kirpalani H
    Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant lung lavage using asymmetric high-frequency jet ventilation followed by conventional ventilation in rabbits with meconium aspiration.
    Mokra D; Calkovska A; Drgova A; Javorka K
    Bratisl Lek Listy; 2005; 106(12):412-5. PubMed ID: 16642667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant Lung Lavage vs. Standard Care in the Treatment of Meconium Aspiration Syndrome-A Randomized Trial.
    Bandiya P; Nangia S; Saili A
    J Trop Pediatr; 2019 Apr; 65(2):114-121. PubMed ID: 29878264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactant lavage for meconium aspiration syndrome: a pilot study.
    Lam BC; Yeung CY
    Pediatrics; 1999 May; 103(5 Pt 1):1014-8. PubMed ID: 10224181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid therapy for meconium aspiration syndrome in newborn infants.
    Ward M; Sinn J
    Cochrane Database Syst Rev; 2003; 2003(4):CD003485. PubMed ID: 14583981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant therapy for meconium aspiration syndrome in neonates: a systematic overview of systematic reviews and recent clinical trials.
    Abdelaal MA; Abushanab D; Al-Badriyeh D
    J Comp Eff Res; 2020 Jun; 9(8):527-536. PubMed ID: 32394731
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO.
    Gadzinowski J; Kowalska K; Vidyasagar D
    J Perinatol; 2008 Dec; 28 Suppl 3():S56-66. PubMed ID: 19057612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An effectiveness of surfactant lung lavage (SLL) in meconium aspiration syndrome (MAS)].
    Kowalska K; Szymankiewicz M; Gadzinowski J
    Przegl Lek; 2002; 59 Suppl 1():21-4. PubMed ID: 12108066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic lung lavage in meconium aspiration syndrome: a preliminary report.
    Dargaville PA; Mills JF; Copnell B; Loughnan PM; McDougall PN; Morley CJ
    J Paediatr Child Health; 2007; 43(7-8):539-45. PubMed ID: 17635682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchoalveolar lavage versus bolus administration of lucinactant, a synthetic surfactant in meconium aspiration in newborn lambs.
    Rey-Santano C; Alvarez-Diaz FJ; Mielgo V; Murgia X; Lafuente H; Ruiz-Del-Yerro E; Valls-I-Soler A; Gastiasoro E
    Pediatr Pulmonol; 2011 Oct; 46(10):991-9. PubMed ID: 21520434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine oro/nasopharyngeal suction versus no suction at birth.
    Foster JP; Dawson JA; Davis PG; Dahlen HG
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010332. PubMed ID: 28419406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary function after surfactant lung lavage followed by surfactant administration in infants with severe meconium aspiration syndrome.
    Szymankiewicz M; Gadzinowski J; Kowalska K
    J Matern Fetal Neonatal Med; 2004 Aug; 16(2):125-30. PubMed ID: 15512724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchoalveolar lavage with diluted porcine surfactant in mechanically ventilated term infants with meconium aspiration syndrome.
    Lista G; Bianchi S; Castoldi F; Fontana P; Cavigioli F
    Clin Drug Investig; 2006; 26(1):13-9. PubMed ID: 17163230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.